Affiliation:
1. School of Pharmaceutical Sciences; Sun Yat-sen University; Guangzhou; 510006; China
2. Department of Pharmacokinetics, Dynamics and Metabolism; Pfizer Inc.; Groton; CT; 06340; USA
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry
Reference16 articles.
1. Bristol-Myers Squibb Data on file Bristol-Myers Squibb Pharmaceutical Research Institute 2003
2. Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors;Deacon;Diabetes, Obesity & Metabolism,2007
3. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections;Fura;Drug Metabolism and Disposition,2009
4. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes;Gallwitz;IDrugs,2008
5. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes;Hellum;Basic & Clinical Pharmacology & Toxicology,2007
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献